News

Siemens Healthineers AG offers 15%+ annualized upside with strong fundamentals. Click here to find out why SEMHF stock is a ...
The global mammography equipment market is projected to grow from $3.1 billion in 2025 to $4 billion by 2030, at a CAGR of ...
Siemens Healthineers has earned My Green Lab ACT Ecolabel Certification for more than 150 reagents used by medical laboratories for patient testing.
Apollo Hospitals and Siemens Healthineers launch a groundbreaking collaboration to enhance liver disease management through ...
The collaboration aims to develop clinical solutions using AI and ultrasound technologies to enhance early detection and ...
Apollo Hospitals and Siemens Healthineers collaborate on AI-driven liver disease research for improved diagnostics and ...
Nassif, who will also join Neogen’s Board of Directors, succeeds John Adent who is stepping down after eight years with the company. Nassif currently serves as Global President of the Point-of-Care ...
View the latest Siemens Healthineers AG ADR (SMMNY) stock price, news, historical charts, analyst ratings and financial information from WSJ.
About Siemens Healthineers AG. Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of healthcare. As a leading medical technology company headquartered in Erlangen, ...
Siemens Healthineers announces that the U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test,1, ...
Siemens Healthineers expects medium-term earnings per share growth averaging 12% to 15% annually through fiscal 2025. The company will have to deliver on this growth to justify the high P/E ratio.
Apollo Hospitals and Siemens Healthineers on Wednesday announced a research collaboration founded on a shared ambition to advance innovations in artificial intelligence (AI) and imaging technologies, ...